Evaluation of occult acetaminophen hepatotoxicity in hospitalized children receiving acetaminophen

Clinical Pediatrics

Volumn 40, Issue 5, 2001, Pages 243-248

  James, Laura P ^a   Wilson, John T ^c   Simar, Renee ^c   Farrar, Henry C ^a   Kearns, Gregory L ^d   Simpson, Pippa M ^b   Hinson, Jack A ^e   Pumford, Neil R ^e  

^a ARKANSAS CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c Louisiana State University School of Medicine Shreveport   (United States)

^d UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^e UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CARBAMAZEPINE; CYTOCHROME P450; GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE; LIVER PROTEIN; PARACETAMOL; PHENOBARBITAL; PHENYTOIN; RIFAMPICIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHILD HOSPITALIZATION; DRUG EFFECT; DRUG METABOLISM; DRUG SAFETY; FEMALE; HUMAN; INFANT; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; NEWBORN; PILOT STUDY; UNITED STATES;

EID: 0035016395     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/000992280104000501     Document Type: Article

References (28)

1. Alonso EM, Sokol RJ, Hart J, et al. Fulminant hepatitis associated with centrilobular hepatic necrosis in young children. J Pediatr. 1995;127:888-894.
2. Rivera-Penera T, Gugig R, David J, et al. Outcome of acetaminophen overdose in pediatric patients and factors contributing to hepatotoxicity. J Pediatr. 1997;130:300-304.
3. Heubi JE, Barbacci MB, Zimmerman HJ. Therapeutic misadventures with acetaminophen: hepatotoxicity after multiple doses in children. J Pediatr. 1998;132:22-27.
4. Schiodt FV, Rochling FA, Casey DL, Lee WM. Acetaminophen toxicity in an urban county hospital. N Engl J Med. 1997;337:1112-1117.
5. Johnston SC, Pelletier LL. Enhanced hepatotoxicity of acetaminophen in the alcoholic patient: two case reports and a review of the literature. Medicine. 1997;76:185-191.
6. Zimmerman HJ, Maddrey WC. Acetaminophen (Paracetamol) hepatotoxicity with regular intake of alcohol: analysis of instances of therapeutic misadventure. Hepatology. 1995;22: 767-773.
7. Burkhart KK, Donovan JW. Severe act etaminophen hepatic and renal toxicity following postoperative therapeutic doses. Abstract. J Tox Clin Tox. 2000;38:569.
8. Pumford NR, Halmes NC. Protein targets of xenobiotic reactive intermediates. Annu Rev Pharmacol Ther. 1997; 37:91-117.
9. Hinson JA, Pumford NR, Roberts DW. Mechanisms of acetaminophen toxicity: immunochemical detection of drug-protein adducts. Drug Metab Rev. 1995;27:73-92.
10. Roberts DW, Pumford NR, Potter DW, et al. A sensitive immunochemical assay for acetaminophen-protein adducts. J Pharmacol Exp Ther. 1987;241:527-533.
11. Roberts DW, Benson RW, Pumford NR, et al. Sensitive immunochemical assays for monitoring acetaminophen toxicity in humans. In: Vanderlaan M, Stanker LH, Watkins BE, Roberts DW, eds. Immunoassays for Trace Chemical Analysis. Washington: ACS Books; 1991:314-326.
12. Roberts DW, Bucci TJ, Benson RW, et al. Immunohistochemical localization and quantification of the 3(Cystein-S-yl)-acetaminophen protein adduct in acetaminophen hepatotoxicity. Am J Pathol. 1991;138:359-371.
13. James LP, Farrar HC, Sullivan JE, et al. Measurement of acetaminophen-protein adducts in children and adolescents with acetaminophen overdoses. Submitted to J Clinical Pharmacology, February 2001.
14. Webster PA, Roberts DW, Benson RW, Kearns GL. Acetaminophen toxicity in children: diagnostic confirmation using a specific antigenic biomarker. J Clin Pharmacol. 1997;36:397-402.
15. Lauterburg BH, Velez ME. Glutathione deficiency in alcoholics: risk factor for paracetamol hepatotoxicity. Gut. 1988;29:1153-1157.
16. Minton NA, Henry JA, Frankel RJ. Fatal paracetamol poisoning in an epileptic. Human Toxicol. 1988;7:33:34.
17. Murphy R, Schwartz R, Watkins PB. Severe acetaminophen toxicity in a patient receiving isoniazid. Ann Intern Med. 1990;113:799-800.
18. Wilson JT, Kasantikul V, Harbison R, Martin D. Death in an adolescent following overdose of acetaminophen and phenobarbital. Am J Dis Child. 1978;132:466-473.
19. Nolan CM, Sandblom RE, Thummel KE, et al. Hepatotoxicity associated with acetaminophen usage in patients receiving multiple drug therapy for tuberculosis. Chest. 1994;105:408-411.
20. Matthews AM, Roberts DW, Hinson JA, Pumford NR. Acetaminophen-influced hepatotoxicity: analysis of total covalent binding versus specific binding to cysteine. Drug Metab Dispos. 1996;24:1192-1196.
21. Eriksson LS, Broome U. Kalin M, Lindholm M. Hepatotoxicity due to repeated intake of low doses of paracetamol. J Intern Med. 1992:231:567-570.
22. Kearns GL, Leeder JS, Wasserman GS. Acetaminophen overdose with therapeutic intent. J Pediatr. 1998;132:5-8.
23. Renton KW, Armstrong SG. Immune-mediated downregulation of cytochrome P450 and related drug biotransformation. In: Dean JH, Luster MI, Munson AE, Kimber I, eds. Immunotoxicology and Immunopharmacology, 2nd ed. New York: Raben Press, Ltd; 1994:501-512.
24. Macdonald MG, McCrath PP, McMartin DN. Potentiation of the toxic effects of acetaminophen in mice by concurrent infection with influenza B virus: a possible mechanism for human Reye's syndrome. Pediatr Res. 1984;18:181-187.
25. Nicod L, Viollon C, Regnier A, et al. Rifampin and isoniazid increase acetaminophen and isoniazid cytotoxicity in human HepG2 hepatoma cells. Hum Ex Toxicol. 1997;16:28-34.
26. Kuffner E, Dart RC, Bogdan GM, et al. Evaluation of hepatotoxicity in alcoholic patients from therapeutic dosing of acetaminophen. Abstract. J Tox Clin Tox. 1999;37:143.
27. Schiedel D, Tucker J, Wijsman J, Rieder MJ. Alterations in intracellular glutathione levels in peripheral blood mononuclear cells of HIV patients during sulfonamide therapy. Clin Pharmacol Ther. 1999;65:159 (abstract).
28. Buhl R. Jaffe HA, Holroyd KJ, et al. Systemic glutathione deficiency in symptom-free HIV-seropositive individuals. Lancet. 1989;2:1294-1298.